| Title: | Harmonizing Health States: Unraveling Specific Multi-Omics Paradigms through the Integration of Genotype-Phenotype Associations and Clinical Biochemical Indicators |
| Lead Institution: | Beijing ClouDNA Technology Company Limited |
| Principal investigator: |
Application 220689
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
This research initiative aims to dissect the intricate nexus of genetic and environmental determinants underlying complex diseases and sub-health states. Through an exhaustive exploration of the human genome, we aspire to elucidate the nuanced contributions of minor genetic variations and their interactions with environmental factors, particularly in the context of prevalent conditions such as diabetes and cardiovascular diseases. Our dataset is meticulously curated to encompass a broad demographic spectrum, ensuring a comprehensive analysis inclusive of diverse age groups, genders, and ethnic backgrounds. The principal objective is the identification of specific genetic patterns intricately associated with diverse health conditions. Beyond the genomic realm, the study extends into the epigenome, delving into the regulatory mechanisms governing gene expression. This dual focus on genetic inheritance and epigenetic regulation is poised to unveil latent molecular pathways, with transformative implications for the paradigm of personalized medicine. The project envisions a three-year launch, dedicated to methodical investigation and discovery. Our pursuit extends beyond mere scientific milestones; the ultimate aim is a direct and substantive impact on public health. Envision a diagnostic framework that transcends conventional models, integrating unique genetic and environmental considerations for enhanced precision. Concurrently, the project aspires to catalyze the development of tailored therapeutic modalities, minimizing adverse effects and maximizing therapeutic efficacy. This vision aligns with a future where healthcare is tailored to the individual's genetic makeup and lifestyle, heralding a departure from the conventional one-size-fits-all approach. The undertaking of unraveling the genetic and epigenetic landscape mirrors the decryption of a complex code, with profound implications for disease comprehension and intervention. While the project's temporal expanse is substantive, the foreseen impact is enduring, holding the promise of ushering in a transformative era characterized by a refined, personalized healthcare ethos for posterity.1 Publication
| Pub ID | Title | Author(s) | Year | Journal |
|---|---|---|---|---|
| 17440 | Associations of Chronic Rhinosinusitis and Nasal Polyps With Elevated Venous Thromboembolism Risk: Evidence From the UK Biobank | Shenglong Xu (+5) | 2026 | Allergy |
Enabling scientific discoveries that improve human health